{"url_path":"/sec/agtx/10-k/2026/item-8","section_key":"item-8","section_title":"Item 8 ** **Financial Statements.**","topic":"sec","document":{"doc_type":"10-K","doc_date":"2026-07-01","source_url":"https://www.sec.gov/Archives/edgar/data/1603345/0001477932-26-004133-index.html","accession_number":"0001477932-26-004133","cik":"0001603345","ticker":"AGTX","issuer_name":"Agentix Corp.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1603345/0001477932-26-004133-index.html","primary_entity_key":"0001603345","primary_entity_name":"Agentix Corp."},"word_count":6716,"has_tables":true,"body_markdown":"**Item 8.** **Financial Statements.**\n\n \n\n**Agentix Corp.**\n\n**Index to the Financial Statements**\n\n \n\n**Contents**\n\n \n\n**Page(s)**\n\n \n\n \n\n \n\n \n\n \n\n[Report of Independent Registered Public Accounting Firm (PCAOB ID: 05525)](#REP001)\n\n \n\nF-2\n\n \n\n[Consolidated Balance Sheets at March 31, 2026 and March 31, 2025](#BS)\n\n \n\nF-3\n\n \n\n[Consolidated Statements of Operations for the years ended March 31, 2026 and March 31, 2025](#SO)\n\n \n\nF-4\n\n \n\n[Consolidated Statements of Changes in Stockholders’ Deficit for the Years Ended March 31, 2026 and 2025](#SE)\n\n \n\nF-5\n\n \n\n[Consolidated Statements of Cash Flows for the years ended March 31, 2026 and 2025](#CF)\n\n \n\nF-6\n\n \n\n[Notes to the financial statements](#NTS)\n\n \n\nF-7\n\n \n\n \n\n \n\nF-1\n\n*Table of Contents*\n\n \n\n \n\n**REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM**\n\n \n\nTo the Board of Directors and Stockholders of Agentix Corp.\n\n \n\n**Opinion on the Financial Statements**\n\n \n\nWe have audited the accompanying consolidated balance sheets of Agentix Corp. (“the Company”) as of March 31, 2026 and 2025, and the related consolidated statements of operations, changes in stockholders’ deficit, and cash flows for each of the years in the two-year period ended March 31, 2026, and the related notes (collectively referred to as the financial statements). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of March 31, 2026 and 2025, and the results of its operations and its cash flows for each of the years in the two-year period ended March 31, 2026, in conformity with accounting principles generally accepted in the United States of America.\n\n \n\n**Going Concern**\n\n \n\nThe accompanying financial statements have been prepared assuming that the Company will continue as a going concern. As discussed in Note 1 to the financial statements, the Company has an accumulated deficit, net losses, and negative cash flows from operations. These factors, among others, raise substantial doubt about the Company’s ability to continue as a going concern. Management’s plans in regard to these matters are also described in Note 1. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.\n\n \n\n**Basis for Opinion**\n\n \n\nThese financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.\n\n \n\nWe conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits, we are required to obtain an understanding of internal control over financial reporting, but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion.\n\n \n\nOur audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.\n\n \n\n**Critical Audit Matters**\n\n \n\nCritical audit matters are matters arising from the current period audit of the financial statements that were communicated or required to be communicated to the audit committee and that (1) relate to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments. We determined that there were no critical audit matters.\n\n \n\n \n\nFruci & Associates II, PLLC – PCAOB ID #05525\n\nWe have served as the Company’s auditor since 2018.\n\n \n\nSpokane, Washington\n\nJune 30, 2026\n\n \n\n \n\nF-2\n\n*Table of Contents*\n\n \n\n**Agentix Corp. and Subsidiaries**\n\n**Consolidated Balance Sheets**\n\n \n\n \n\n \n\n**March 31, 2026**\n\n \n\n \n\n**March 31, 2025**\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n**Assets**\n\n \n\n \n\n \n\n \n\n \n\n \n\n**Current Assets**\n\n \n\n \n\n \n\n \n\n \n\n \n\nCash\n\n \n$771\n \n\n \n$4,477\n \n\nPrepaid expense and other current assets\n\n \n\n \n-\n \n\n \n\n \n95,797\n \n\n**Total current assets**\n\n \n\n \n771\n \n\n \n\n \n100,274\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n**Total assets**\n\n \n$771\n \n\n \n$100,274\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n**Liabilities and Stockholders' Deficit**\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n**Current Liabilities**\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nAccounts payable\n\n \n$715,870\n \n\n \n$968,888\n \n\nAccounts payable - related parties\n\n \n\n \n2,383,073\n \n\n \n\n \n1,932,438\n \n\nNote payable - related party\n\n \n\n \n353,450\n \n\n \n\n \n243,000\n \n\nAccrued expenses\n\n \n\n \n143,889\n \n\n \n\n \n60,197\n \n\nTotal current liabilities\n\n \n\n \n3,596,282\n \n\n \n\n \n3,204,523\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n**Long Term Liabilities**\n\n \n\n \n-\n \n\n \n\n \n-\n \n\nTotal liabilities\n\n \n\n \n3,596,282\n \n\n \n\n \n3,204,523\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n**Commitments and Contingencies**\n\n \n\n \n-\n \n\n \n\n \n-\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n**Stockholders' Deficit**\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nCommon stock par value $0.001: 50,000,000 shares authorized; 40,066,951 shares issued and outstanding as of March 31, 2026 and March 31, 2025, respectively\n\n \n\n \n40,067\n \n\n \n\n \n40,067\n \n\nCommon stock to be issued (357,102 at March 31, 2026 and March 31, 2025, respectively)\n\n \n\n \n53,535\n \n\n \n\n \n53,535\n \n\nAdditional paid-in capital\n\n \n\n \n3,288,296\n \n\n \n\n \n3,288,296\n \n\nAccumulated other comprehensive income\n\n \n\n \n29,755\n \n\n \n\n \n35,381\n \n\nAccumulated deficit\n\n \n\n \n(7,007,164 )\n \n\n \n(6,521,528 )\n\nTotal stockholders' deficit\n\n \n\n \n(3,595,511 )\n \n\n \n(3,104,249 )\n\n**Total liabilities and stockholders' deficit**\n\n \n$771\n \n\n \n$100,274\n \n\n \n\n*See accompanying notes to the consolidated financial statements.*\n\n \n\n \n\nF-3\n\n*Table of Contents*\n\n \n\n**Agentix Corp. and Subsidiaries**\n\n**Consolidated Statements of Operations**\n\n \n\n \n\n \n\n**Twelve Months**\n\n \n\n \n\n**Twelve Months**\n\n \n\n \n\n \n\n**Ended**\n\n \n\n \n\n**Ended**\n\n \n\n \n\n \n\n**March 31, 2026**\n\n \n\n \n\n**March 31, 2025**\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nOperating Expenses\n\n \n\n \n\n \n\n \n\n \n\n \n\nProfessional fees\n\n \n$252,036\n \n\n \n$262,366\n \n\nResearch and development\n\n \n\n \n125,079\n \n\n \n\n \n180,987\n \n\nGeneral and administrative expenses\n\n \n\n \n68,072\n \n\n \n\n \n69,898\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nTotal operating expenses\n\n \n\n \n445,187\n \n\n \n\n \n513,251\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nLoss from operations\n\n \n\n \n(445,187 )\n \n\n \n(513,251 )\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nOther (income) expense\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nForeign exchange gain (loss)\n\n \n\n \n(24,584 )\n \n\n \n11,128\n \n\nInterest expense, net\n\n \n\n \n80,106\n \n\n \n\n \n42,669\n \n\nInterest income\n\n \n\n \n-\n \n\n \n\n \n-\n \n\nOther income\n\n \n\n \n(15,073 )\n \n\n \n-\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nOther loss (income), net\n\n \n\n \n40,449\n \n\n \n\n \n53,797\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nLoss before income tax provision\n\n \n\n \n(485,636 )\n \n\n \n(567,048 )\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nIncome tax provision\n\n \n\n \n-\n \n\n \n\n \n-\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nNet loss\n\n \n$(485,636 )\n \n$(567,048 )\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nOther comprehensive income\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nChange in foreign currency translation, net of tax\n\n \n\n \n9,037\n \n\n \n(23,020 )\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nTotal comprehensive loss\n\n \n\n$ \n(476,599)\n \n\n$ \n(602,216 )\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nLoss per share\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n- Basic and diluted\n\n \n$(0.01 )\n \n$(0.01 )\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nWeighted average common shares outstanding\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n- Basic and diluted\n\n \n\n \n40,066,951\n \n\n \n\n \n40,066,951\n \n\n \n\n*See accompanying notes to the consolidated financial statements.*\n\n \n\n \n\nF-4\n\n*Table of Contents*\n\n \n\n**Agentix Corp. and Subsidiaries**\n\n**Consolidated Statements of Changes in Stockholders’ Deficit**\n\n**For the Years Ended March 31, 2026 and 2025**\n\n \n\n \n\n \n\n**Common stock par**\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n** value $0.001**\n\n \n\n \n\n** Common**\n\n \n\n \n\n**Additional**\n\n \n\n \n\n**Other**\n\n \n\n \n\n \n\n \n\n \n\n**Total**\n\n \n\n \n\n \n\n**Number of**\n\n \n\n \n\n \n\n \n\n \n\n**Stock to be**\n\n \n\n \n\n** Paid-in**\n\n \n\n \n\n**Comprehensive**\n\n \n\n \n\n** Accumulated**\n\n \n\n \n**Stockholders'**\n \n\n \n\n \n\n**Shares**\n\n \n\n \n\n** Amount**\n\n \n\n \n\n**Issued**\n\n \n\n \n\n**Capital**\n\n \n\n \n\n**Income**\n\n \n\n \n\n**Deficit**\n\n \n\n \n\n**Deficit**\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nBalance, March 31, 2024\n\n \n\n \n40,066,951\n \n\n \n$40,067\n \n\n \n$53,535\n \n\n \n$3,288,296\n \n\n \n$12,360\n \n\n \n$(5,954,480)\n \n$(2,560,222)\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nForeign exchange translation income\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n23,021\n \n\n \n\n \n\n \n\n \n\n \n\n \n23,021\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nNet Loss\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n(567,048)\n \n\n \n(567,048)\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nBalance, March 31, 2025\n\n \n\n \n40,066,951\n \n\n \n$40,067\n \n\n \n$53,535\n \n\n \n$3,288,296\n \n\n \n$35,381\n \n\n \n$(6,521,528)\n \n$(3,104,249)\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nForeign exchange translation loss\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n(9,037)\n \n\n \n\n \n\n \n\n \n\n \n(9,037)\n\nNet Loss\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n(485,636)\n \n\n \n(485,636)\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nBalance, March 31, 2026\n\n \n\n \n40,066,951\n \n\n \n$40,067\n \n\n \n$53,535\n \n\n \n$3,288,296\n \n\n \n$29,755\n \n\n \n$(7,007,164)\n \n$(3,595,511)\n\n \n\n*See accompanying notes to the consolidated financial statements.*\n\n \n\n \n\nF-5\n\n*Table of Contents*\n\n \n\n**Agentix Corp. and Subsidiaries**\n\n**Consolidated Statement of Cash Flows**\n\n \n\n \n\n \n\n**Twelve Months**\n\n \n\n \n\n**Twelve Months**\n\n \n\n \n\n \n\n**Ended**\n\n \n\n \n\n**Ended**\n\n \n\n \n\n \n\n**March 31, 2026**\n\n \n\n \n\n**March 31, 2025**\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n**Cash Flows from Operating Activities**\n\n \n\n \n\n \n\n \n\n \n\n \n\nNet loss\n\n \n$(485,636 )\n \n$(567,048 )\n\nAdjustments to reconcile net loss to net cash used in operating activities:\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nGain on settlement of payables\n\n \n\n \n(20,604\n) \n\n \n\n \n-\n \n\nChanges in operating assets and liabilities:\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nPrepayments and other current assets\n\n \n\n \n95,798\n \n\n \n\n \n4,041\n \n\nAccrued expenses, accounts payable and accounts payable-related party\n\n \n\n \n301,913\n \n\n \n\n \n437,929\n \n\n**Net Cash Provided by (Used in) Operating Activities**\n\n \n\n \n(108,529 )\n \n\n \n(125,078 )\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n**Cash Flows from Investing Activities**\n\n \n\n \n-\n \n\n \n\n \n-\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n**Cash Flows from Financing Activities**\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nProceeds from issuance of debt\n\n \n\n \n110,450\n \n\n \n\n \n100,000\n \n\n**Net Cash Provided by Financing Activities**\n\n \n\n \n110,450\n \n\n \n\n \n100,000\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n**Effects of Foreign Exchange Rate Changes on Cash**\n\n \n\n \n(5,627 )\n \n\n \n23,020\n \n\n**Net Change in Cash**\n\n \n\n \n(3,706\n)\n\n \n\n \n(2,058 )\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n**Cash - beginning of reporting period**\n\n \n\n \n4,477\n \n\n \n\n \n6,535\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n**Cash - end of reporting period**\n\n \n$771\n \n\n \n$4,477\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n**Supplemental disclosure of cash flow information:**\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nInterest paid\n\n \n$-\n \n\n \n$-\n \n\nIncome tax paid\n\n \n$-\n \n\n \n$-\n \n\n \n\n*See accompanying notes to the consolidated financial statements.*\n\n \n\n \n\nF-6\n\n*Table of Contents*\n\n \n\n**Note 1 - Organization and Basis of Presentation**\n\n \n\n*Description of the Company*\n\n \n\nFairWind Energy, Inc. (the \"Company\") was incorporated on April 18, 2013 under the laws of the State of Nevada. Effective June 17, 2019, the Company changed its name to Agentix Corp. In March 2022, the Company changed its fiscal year end from August to March.\n\n \n\nThe Company is a clinical-stage biotechnology company developing therapeutic agents for the treatment of metabolic disease like Type 2 diabetes mellitus, obesity, non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH).\n\n \n\n*Going Concern*\n\n \n\nThe Company’s consolidated financial statements have been prepared assuming that it will continue as a going concern, which contemplates continuity of operations, realization of assets, and liquidation of liabilities in the normal course of business.\n\n \n\nAs reflected in the consolidated financial statements, the Company had an accumulated deficit on March 31, 2026, negative cash from operations for the years ended March 31, 2026 and 2025, and a net loss for the years ended March 31, 2026 and 2025. These factors raise substantial doubt about the Company’s ability to continue as a going concern. Cash on hand as of March 31, 2026 was $771.\n\n \n\nThe Company is attempting to commence operations and generate sufficient revenue; however, the Company’s cash position is not sufficient to support its daily operations and it will need further funding. The ability of the Company to continue as a going concern is dependent upon its ability to further implement its business plan and generate sufficient revenue and its ability to raise additional funds.\n\n \n\nThe consolidated financial statements do not include any adjustments related to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.\n\n \n\n*Principles of Consolidation*\n\n \n\nThe consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries, GSL Healthcare, Inc., AB Merger LLC, Agentix Australia Pty Ltd, and Applied Biopharma, all of which are 100% owned by the Company. All intercompany transactions and balances have been eliminated in consolidation.\n\n \n\nExcept for Agentix Australia Pty Ltd, the Company’s subsidiaries had no material operations or activity during the periods presented. Agentix Australia Pty Ltd is included in continuing operations.\n\n \n\n**Note 2 - Significant and Critical Accounting Policies and Practices**\n\n \n\n*Basis of Presentation*\n\n \n\nThe accompanying consolidated financial statements and related notes have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”), and with the rules and regulations of the United States Securities and Exchange Commission (“SEC”) to Form 10-K and Article 8 of Regulation S-X. These consolidated financial statements should be read in conjunction with the notes herein.\n\n \n\n \n\nF-7\n\n*Table of Contents*\n\n \n\n** \n\n*Fair Value of Financial Instruments*\n\n \n\nThe Company follows paragraph 825-10-50-10 of the FASB Accounting Standards Codification for disclosures about fair value of its financial instruments and paragraph 820-10-35-37 of the FASB Accounting Standards Codification (“Paragraph 820-10-35-37”) to measure the fair value of its financial instruments. Paragraph 820-10-35-37 establishes a framework for measuring fair value in generally accepted accounting principles (GAAP) and expands disclosures about fair value measurements. To increase consistency and comparability in fair value measurements and related disclosures, Paragraph 820-10-35-37 establishes a fair value hierarchy which prioritizes the inputs to valuation techniques used to measure fair value into three (3) broad levels. The fair value hierarchy gives the highest priority to quoted prices (unadjusted) in active markets for identical assets or liabilities and the lowest priority to unobservable inputs. The three (3) levels of fair value hierarchy defined by Paragraph 820-10-35-37 are described below:\n\n \n\nLevel 1\n\nQuoted market prices available in active markets for identical assets or liabilities as of the reporting date.\n\n \n\n \n\nLevel 2\n\nPricing inputs other than quoted prices in active markets included in Level 1, which are either directly or indirectly observable as of the reporting date.\n\n \n\n \n\nLevel 3\n\nPricing inputs that are generally unobservable inputs and not corroborated by market data.\n\n \n\nFinancial assets are considered Level 3 when their fair values are determined using pricing models, discounted cash flow methodologies or similar techniques and at least one significant model assumption or input is unobservable.\n\n \n\nThe fair value hierarchy gives the highest priority to quoted prices (unadjusted) in active markets for identical assets or liabilities and the lowest priority to unobservable inputs. If the inputs used to measure the financial assets and liabilities fall within more than one level described above, the categorization is based on the lowest level input that is significant to the fair value measurement of the instrument.\n\n \n\nThe carrying amounts of the Company’s financial assets and liabilities, such as cash, accounts payable and accrued expenses approximate their fair values because of the short maturity of these instruments. The Company’s equity investments are considered Level 3, as pricing inputs are generally unobservable and not corroborated by market data.\n\n \n\n*Prepayments*\n\n \n\nPrepayments consisted of the following:\n\n \n\n \n\n·\n\n$0 and $95,797 as of March 31, 2026 and 2025, respectively, related to obligations for clinical research for which the Company is obligated to pay, but has not recorded the expense as the related services were not completed by the vendor as of March 31, 2026 and 2025.\n\n \n\n \n\n \n\n \n\n·\n\nThere was no prepaid software as of March 31, 2026 and 2025.\n\n \n\n*Carrying Value, Recoverability and Impairment of Long-Lived Assets*\n\n \n\nThe Company follows Section 360-10-35 of the FASB Accounting Standards Codification for its long-lived assets. Pursuant to ASC Paragraph 360-10-35-17 an impairment loss shall be recognized only if the carrying amount of a long-lived asset (asset group) is not recoverable and exceeds its fair value. The carrying amount of a long-lived asset (asset group) is not recoverable if it exceeds the sum of the undiscounted cash flows expected to result from the use and eventual disposition of the asset (asset group). That assessment shall be based on the carrying amount of the asset (asset group) at the date it is tested for recoverability. An impairment loss shall be measured as the amount by which the carrying amount of a long-lived asset (asset group) exceeds its fair value. Pursuant to ASC Paragraph 360-10-35-20 if an impairment loss is recognized, the adjusted carrying amount of a long-lived asset shall be its new cost basis. For a depreciable long-lived asset, the new cost basis shall be depreciated (amortized) over the remaining useful life of that asset. Restoration of a previously recognized impairment loss is prohibited.\n\n \n\n \n\nF-8\n\n*Table of Contents*\n\n \n\n \n\nPursuant to ASC Paragraph 360-10-35-21 the Company’s long-lived asset (asset group) is tested for recoverability whenever events or changes in circumstances indicate that its carrying amount may not be recoverable. The Company considers the following to be some examples of such events or changes in circumstances that may trigger an impairment review: (a) significant decrease in the market price of a long-lived asset (asset group); (b) A significant adverse change in the extent or manner in which a long-lived asset (asset group) is being used or in its physical condition; (c) A significant adverse change in legal factors or in the business climate that could affect the value of a long-lived asset (asset group), including an adverse action or assessment by a regulator; (d) An accumulation of costs significantly in excess of the amount originally expected for the acquisition or construction of a long-lived asset (asset group); (e) A current-period operating or cash flow loss combined with a history of operating or cash flow losses or a projection or forecast that demonstrates continuing losses associated with the use of a long-lived asset (asset group); and (f) A current expectation that, more likely than not, a long-lived asset (asset group) will be sold or otherwise disposed of significantly before the end of its previously estimated useful life. The Company tests its long-lived assets for potential impairment indicators at least annually and more frequently upon the occurrence of such events.\n\n \n\nPursuant to ASC Paragraphs 360-10-45-4 and 360-10-45-5 an impairment loss recognized for a long-lived asset (asset group) to be held and used shall be included in income from continuing operations before income taxes in the income statement of a business entity. If a subtotal such as income from operations is presented, it shall include the amount of that loss. A gain or loss recognized on the sale of a long-lived asset (disposal group) that is not a component of an entity shall be included in income from continuing operations before income taxes in the income statement of a business entity. If a subtotal such as income from operations is presented, it shall include the amounts of those gains or losses.\n\n \n\n*Cash Equivalents*\n\n \n\nThe Company considers all highly liquid investments with maturities of three months or less at the time of purchase to be cash equivalents.\n\n \n\n*Commitment and Contingencies*\n\n \n\nThe Company accounts for contingencies in accordance with ASC 450-20, *Loss Contingencies*. Certain conditions may exist as of the date the financial statements are issued that may result in a loss to the Company, but which will only be resolved when one or more future events occur or fail to occur. The Company assesses such contingent liabilities based on available information, and such assessment inherently involves the exercise of judgment.\n\n \n\nIn assessing loss contingencies related to pending legal proceedings or unasserted claims that may result in legal proceedings, the Company evaluates the perceived merits of the matter, the likelihood of an unfavorable outcome, and the amount of relief sought or expected to be sought. If the assessment indicates that it is probable that a loss has been incurred and the amount of the liability can be reasonably estimated, the Company accrues the estimated liability in the financial statements. If the assessment indicates that a potential material loss contingency is not probable but is reasonably possible, or is probable but the amount cannot be reasonably estimated, the Company discloses the nature of the contingency and an estimate of the possible loss or range of loss, if such estimate can be made and is material. Loss contingencies considered remote are generally not disclosed unless they involve guarantees.\n\n \n\nThe Company has received correspondence from a vendor alleging that approximately $44,991 remains outstanding in connection with prior services allegedly provided to Agentix Australia Pty Ltd. The vendor has indicated that it has commenced debt recovery action and may pursue formal legal proceedings if the amount is not resolved. Management disputes certain aspects of the vendor’s claim, including whether the amounts are valid and payable; however, the Company has accrued the asserted amount in the accompanying consolidated financial statements.\n\n \n\nAs of March 31, 2026, other than the matter described above, the Company is not aware of any material pending or threatened claims, commitments, or contingencies that would require additional accrual or disclosure in the consolidated financial statements.\n\n \n\n*Research and Development*\n\n \n\nThe Company follows paragraph 730-10-25-1 of the FASB Accounting Standards Codification (formerly Statement of Financial Accounting Standards No. 2 *“Accounting for Research and Development Costs”*) and paragraph 730-20-25-11 of the FASB Accounting Standards Codification (formerly Statement of Financial Accounting Standards No. 68 *“Research and Development Arrangements”*) for research and development costs. Research and development costs are charged to expense as incurred. Research and development costs consist primarily of remuneration for material and testing costs for research and development.\n\n \n\n*Foreign Currency Translation*\n\n \n\nThe functional currency of the Company’s foreign operation, Agentix Australia Pty Ltd, is deemed to be the local country’s currency (the Australian dollar). Assets and liabilities of Agentix Australia Pty Ltd are translated at their respective period-end exchange rates, and expenses are translated based on the average exchange rate for the period. The resulting balance sheet translation adjustments are included in other comprehensive income and are reflected as a separate component of the stockholder’s deficit.\n\n \n\n*Related Parties*\n\n \n\nThe Company follows subtopic 850-10 of the FASB Accounting Standards Codification for the identification of related parties and disclosure of related party transactions.\n\n \n\nPursuant to Section 850-10-20 the related parties include a. affiliates (“Affiliate” means, with respect to any specified Person, any other Person that, directly or indirectly through one or more intermediaries, controls, is controlled by or is under common control with such Person, as such terms are used in and construed under Rule 405 under the Securities Act) of the Company; b. entities for which investments in their equity securities would be required, absent the election of the fair value option under the Fair Value Option Subsection of Section 825–10–15, to be accounted for by the equity method by the investing entity; c. trusts for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of management; d. principal owners of the Company; e. management of the Company; f. other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests; and g. other parties that can significantly influence the management or operating policies of the transacting parties or that have an ownership interest in one of the transacting parties and can significantly influence the other to an extent that one or more of the transacting parties might be prevented from fully pursuing its own separate interests.\n\n \n\n \n\nF-9\n\n*Table of Contents*\n\n \n\n \n\nThe financial statements shall include disclosures of material related party transactions, other than compensation arrangements, expense allowances, and other similar items in the ordinary course of business. However, disclosure of transactions that are eliminated in the preparation of consolidated or combined financial statements is not required in those statements. The disclosures shall include: a. the nature of the relationship(s) involved; b. a description of the transactions, including transactions to which no amounts or nominal amounts were ascribed, for each of the periods for which income statements are presented, and such other information deemed necessary to an understanding of the effects of the transactions on the financial statements; c. the dollar amounts of transactions for each of the periods for which income statements are presented and the effects of any change in the method of establishing the terms from that used in the preceding period; and d. amounts due from or to related parties as of the date of each balance sheet presented and, if not otherwise apparent, the terms and manner of settlement.\n\n \n\n*Deferred Tax Assets and Income Tax Provision*\n\n \n\nThe Company accounts for income taxes under Section 740-10-30 of the FASB Accounting Standards Codification. Deferred income tax assets and liabilities are determined based upon differences between the financial reporting and tax bases of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. Deferred tax assets are reduced by a valuation allowance to the extent management concludes it is more likely than not that the assets will not be realized. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the statements of operations in the period that includes the enactment date.\n\n \n\nThe Company adopted section 740-10-25 of the FASB Accounting Standards Codification (“Section 740-10-25”). Section 740-10-25 addresses the determination of whether tax benefits claimed or expected to be claimed on a tax return should be recorded in the financial statements. Under Section 740-10-25, the Company may recognize the tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. The tax benefits recognized in the financial statements from such a position should be measured based on the largest benefit that has a greater than fifty percent (50%) likelihood of being realized upon ultimate settlement. Section 740-10-25 also provides guidance on de-recognition, classification, interest and penalties on income taxes, accounting in interim periods and requires increased disclosures.\n\n \n\n*Earnings per Share*\n\n \n\nEarnings per share (“EPS”) are the amount of earnings attributable to each share of common stock. For convenience, the term is used to refer to either earnings or loss per share. EPS is computed pursuant to section 260-10-45 of the FASB Accounting Standards Codification. Pursuant to ASC Paragraphs 260-10-45-10 through 260-10-45-16, basic EPS shall be computed by dividing income available to common stockholders (the numerator) by the weighted-average number of common shares outstanding (the denominator) during the period. Income available to common stockholders shall be computed by deducting both the dividends declared in the period on preferred stock (whether or not paid) and the dividends accumulated for the period on cumulative preferred stock (whether or not earned) from income from continuing operations (if that amount appears in the income statement) and also from net income. The computation of diluted EPS is similar to the computation of basic EPS except that the denominator is increased to include the number of additional common shares that would have been outstanding if the dilutive potential common shares had been issued during the period to reflect the potential dilution that could occur from common shares issuable through contingent shares issuance arrangement, stock options or warrants.\n\n \n\nPursuant to ASC Paragraphs 260-10-45-45-21 through 260-10-45-45-23 Diluted EPS shall be based on the most advantageous conversion rate or exercise price from the standpoint of the security holder. The dilutive effect of outstanding call options and warrants (and their equivalents) issued by the reporting entity shall be reflected in diluted EPS by application of the treasury stock method unless the provisions of paragraphs 260-10-45-35 through 45-36 and 260-10-55-8 through 55-11 require that another method be applied. Equivalents of options and warrants include non-vested stock granted to employees, stock purchase contracts, and partially paid stock subscriptions (see paragraph 260–10–55–23). Anti-dilutive contracts, such as purchased put options and purchased call options, shall be excluded from diluted EPS. Under the treasury stock method: a. Exercise of options and warrants shall be assumed at the beginning of the period (or at time of issuance, if later) and common shares shall be assumed to be issued. b. The proceeds from exercise shall be assumed to be used to purchase common stock at the average market price during the period. (See paragraphs 260-10-45-29 and 260-10-55-4 through 55-5.) c. The incremental shares (the difference between the number of shares assumed issued and the number of shares assumed purchased) shall be included in the denominator of the diluted EPS computation.\n\n \n\nThere were no dilutive common shares for the year ended March 31, 2026 and 2025.\n\n \n\n*Stock-Based Payments*\n\n \n\nStock-based compensation is accounted for based on the requirements of the Share-Based Payment Topic of ASC 718, “Compensation — Stock Compensation” (“ASC 718”), which requires recognition in the financial statements of the cost of employee and director services received in exchange for an award of equity instruments over the period the employee or director is required to perform the services in exchange for the award (presumptively, the vesting period). ASC 718 also requires measurement of the cost of employee and director services received in exchange for an award based on the grant-date fair value of the award.\n\n \n\n \n\nF-10\n\n*Table of Contents*\n\n \n\n \n\nFor non-employees, the Company follows ASU No. 2018-07, Compensation - Stock Compensation (Topic 718): Improvements to Nonemployee Share-Based Payment Accounting. Under the ASU No. 2017-07, most of the guidance on stock payments to nonemployees is aligned with the requirements for share-based payments granted to employees. As such, most of the guidance in ASC 718 associated with employee share-based payments, including most requirements related to classification and measurement, applies to nonemployee share-based payment arrangements.\n\n \n\nNo stock options or warrants were issued or outstanding as of March 31, 2026 and 2025.\n\n \n\n*Recent Accounting Pronouncements*\n\n \n\nIn November 2023, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2023-07, “Improvements to Reportable Segment Disclosures (Topic 280)” which is intended to improve reportable segment disclosure requirements, primarily through incremental disclosures of segment information on an annual and interim basis for all public entities. The ASU expands public entities’ segment disclosures by requiring disclosure of significant segment expenses that are regularly provided to the chief operating decision maker and included within each reported measure of segment profit or loss, an amount and description of its composition for other segment items and interim disclosures of a reportable segment’s profit or loss and assets. The ASU has been applied retrospectively to all prior periods presented in the financial statements and is effective for our Annual Report on Form 10-K for the fiscal year ended March 31, 2026, and interim periods thereafter.\n\n \n\nIn December 2023, the Financial Accounting Standards Board issued Accounting Standards Update No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures (“ASU 2023-09”). ASU 2023-09 enhances income tax disclosure requirements primarily by requiring greater disaggregation of information in the income tax rate reconciliation and additional disclosures regarding income taxes paid by jurisdiction. For public business entities, ASU 2023-09 is effective for annual periods beginning after December 15, 2024. The amendments are required to be applied prospectively, with retrospective application permitted.\n\n \n\nThe Company is currently evaluating the impact of ASU 2023-09 on its consolidated financial statement disclosures. The adoption of ASU 2023-09 is not expected to have a material impact on the Company’s consolidated financial position, results of operations or cash flows, but is expected to result in expanded income tax disclosures.\n\n \n\n*Segment Reporting*\n\n \n\nThe Chief Operating Decision Maker (“CODM”) for the Company is the Chief Executive Officer (the \"CEO\"). The Company’s CEO reviews operating results on an aggregate basis and manages the Company’s operations as a whole for the purpose of evaluating financial performance and allocating resources. This decision-making process reflects the way in which financial information is regularly reviewed and used by the CODM to evaluate performance, set operational targets, forecast future financial results, and allocate resources. Accordingly, the Company has determined that it has a single reportable and operating segment.\n\n \n\nThe Company’s CODM assesses financial performance and allocates resources based on operating results which are also reported on the accompanying consolidated statements of operations. The measure of segment assets is reported on the balance sheet as total consolidated assets. The CODM utilizes consolidated operating results by comparing actual results against budgeted amounts. As part of this process, consolidated net loss is a critical performance measure used to evaluate the Company’s operating performance and guide strategic decisions and resource allocations, including additional investments in research and development.\n\n \n\n*Use of Estimates and Assumptions and Critical Accounting Estimates and Assumptions*\n\n \n\nPreparation of the consolidated financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect certain reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the period. Among other things, management estimates include the assumptions made for accruals and potential liabilities and realization of deferred tax assets. These estimates generally involve complex issues and require judgments, involve analysis of historical information and the prediction of future trends, and are subject to change from period to period. Actual amounts could differ significantly from these estimates.\n\n \n\n**Note 3 - Related Parties**\n\n \n\n*SBS Management LLC*\n\n \n\nDuring the years ended March 31, 2026 and 2025, SBS Management LLC, a company controlled by Mr. Scott Stevens who is a shareholder of the Company, received management consulting fees and made advancement of funds to the Company to pay certain expenses. These expenses consisted of $150,000 and $150,000, respectively, of management fees; $6,000 and $6,000, respectively, for IT expenses; $60,000 and $60,000, respectively, for reimbursement of rent; and advances to the Company to cover certain operating expenses. As of March 31, 2026 and 2025, $1,484,978 and $1,165,491 were included in Accounts payable – related parties on the accompanying consolidated balance sheet. These advances are unsecured, non-interest bearing, and with no formal terms of repayment.\n\n \n\n*Gray’s Peak Capital*\n\n \n\nDuring the years ended March 31, 2026 and 2025, Gray’s Peak Capital (“Gray’s Peak”), a company founded by a shareholder of the Company, made advances to the Company to cover certain operating expenses. These advances are unsecured, non-interest bearing, with no formal terms of repayment. As of March 31, 2026 and 2025, the amounts due Gray’s Peak for these advances were $527,248 and $396,100, respectively, and were included in accounts payable – related parties on the accompanying consolidated balance sheet.\n\n \n\n*Gray’s Peak Capital – Note Payable*\n\n \n\nOn January 15, 2023 and June 15, 2023, the Company entered into two separate Mezzanine Secured Note (“Notes”) in the principal amount up to $200,000 and $500,000, respectively, with Gray’s Peak Private Credit LLC. For 30 days after the date of the Note, the Note bears interest at 7.5%. After the 30th day, the Note bears interest at 2% per month until paid in full. The Note matures and becomes due and payable in full on the 4th and 6th month anniversary of the loan (May 15, 2023 and December 15, 2023). The Company has the option of prepaying any part of the Note in whole or in part without any premium or penalty. In 2023, Gray’s Peak extended the due date of the January 15, 2023 Note to August 31, 2023 and in December 2023, the June 15, 2023 note was extended further to March 31, 2024 and then to September 30, 2024, and the note was further extended to September 30, 2026. The June 15, 2023 amounts borrowed were repaid in September 2023.\n\n \n\n \n\nF-11\n\n*Table of Contents*\n\n \n\n \n\nThe Notes are secured by a pledge by the Company of favor of Gray’s Peak of all of the assets and property of the Company, including without limitation all R&D tax credits, goods, tangible property, machinery, owned equipment, furniture, fixtures, vehicles, parts, accounts, deposit accounts, letter-of-credit rights, chattel paper, contract rights, documents, instruments, investment property, choses in action, general intangibles, goodwill and intellectual property, of any kind or nature, wherever located, in which Company has an interest now or in the future, and which are now existing or hereafter created or acquired, together with any and all additions, replacements, accessions and substitutions thereto or therefore, and any proceeds thereof excluding equipment leased by the Company (collectively called the “Collateral”). Gray’s Peak interest is senior to the unsecured debt or lenders of the Company and the Company’s equity holders. Upon the occurrence of any Event of Default, as defined in the agreement, the principal sum, all accrued and unpaid interest owing thereon and all costs and expenses payable pursuant to this Note, shall, at the sole option of Gray’s Peak and with submission of written notice, become immediately due and payable. \n\n \n\nAs of March 31, 2026 and March 31, 2025, the principal balance outstanding was $353,450 and $243,000, respectively. The notes were included in notes payable – related party on the accompanying consolidated balance sheet of which $143,889 and $60,197 of interest was accrued and included in accrued expenses as of March 31, 2026 and March 31, 2025, respectively.\n\n \n\n*Management*\n\n \n\nAs of March 31, 2026 and 2025, $433,497 and $433,497, respectively, was included in accounts payable – related parties on the accompanying consolidated balance sheet.\n\n \n\n**Note 4 - Equity**\n\n \n\nAs of March 31, 2026 and March 31, 2025, the Company has authorized 50,000,000 shares of common stock at a par value of $0.001 per share and had issued and outstanding shares of common stock of 40,066,951 and 40,066,951, respectively.\n\n \n\n*Shares Issued for Cash*\n\n \n\nDuring the years ended March 31, 2026 and 2025, the Company did not issue any shares for cash.\n\n \n\n*Shares Issued for Services*\n\n \n\nThe Company did not issue any shares for services during the years ended March 31, 2026 and 2025.\n\n \n\nDuring the year ended March 31, 2023, the Company granted 250,000 shares of its common stock to SBS Management LLC in exchange for services previously provided. The shares were valued at a price of $0.17 per share or $42,375, which was the then fair market value as per the market closing price as of the date of the Company’s grant of these shares. As of March 31, 2026 and 2025, these shares had not been issued and were included in common stock to be issued in the consolidated balance sheet.\n\n \n\nDuring the year ended March 31, 2023, the Company granted 307,102 shares of the Company’s common stock in exchange for a one year software subscription, which totaled $32,000. The fair value of the common stock issued was $0.10, which was determined based on the historical market price of the Company’s common stock as of the date of issuance. The fair value determined was amortized ratably over the one-year subscription period to general and administrative expenses. As of March 31, 2026 and 2025, 107,102 shares of the 307,102 shares granted had not been issued and were included in common stock to be issued in the consolidated balance sheet.\n\n \n\n**Note 5 - Deferred Tax Assets and Income Tax Provision**\n\n \n\nThe Company accounts for income taxes in accordance with ASC 740, Income Taxes. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to temporary differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases, as well as net operating loss carryforwards. Deferred tax assets are reduced by a valuation allowance when, based on the weight of available evidence, it is more likely than not that some portion or all of the deferred tax assets will not be realized.\n\n \n\nAt March 31, 2026 and 2025, the Company had net operating loss carryforwards that generated deferred tax assets of approximately $1,470,000 and $1,868,000, respectively. The Company evaluated the positive and negative evidence bearing upon the realizability of its deferred tax assets. Due to the Company's history of operating losses and uncertainty regarding future taxable income, management determined that it is not more likely than not that the deferred tax assets will be realized. Accordingly, the Company recorded a full valuation allowance against its net deferred tax assets as of March 31, 2026 and 2025.\n\n \n\n**The components of the Company's deferred tax assets were as follows:**\n\n \n\n \n\n \n\n**March 31, 2026**\n\n \n\n \n\n**March 31, 2025**\n\n \n\n**Net operating loss carryforwards**\n\n \n$1,470,000\n \n\n \n$1,868,000\n \n\n**Gross deferred tax assets**\n\n \n\n \n1,470,000\n \n\n \n\n \n1,868,000\n \n\nLess: valuation allowance\n\n \n\n \n(1,470,000)\n \n\n \n(1,868,000)\n\n**Net deferred tax assets**\n\n \n$-\n \n\n \n$-\n \n\n \n\n**A reconciliation of the statutory federal income tax rate to the Company's effective tax rate is as follows:**\n\n \n\n \n\n \n\n**Year Ended March 31, 2026**\n\n \n\n \n\n**Year Ended March 31, 2025**\n\n \n\nFederal statutory income tax rate\n\n \n\n \n21.0%\n \n\n \n21.0%\n\nChange in valuation allowance\n\n \n\n \n(21.0)%\n \n\n \n(21.0)%\n\nEffective income tax rate\n\n \n\n \n0.0%\n \n\n \n0.0%\n\n \n\nThe Company's deferred tax assets relate primarily to federal net operating loss carryforwards. Based on the deferred tax asset balance and a 21% federal statutory tax rate, the Company's estimated federal net operating loss carryforwards were approximately $7,000,000 and $8,895,000 as of March 31, 2026 and 2025, respectively.\n\n \n\n \n\n \n\n**March 31, 2026**\n\n \n\n \n\n**March 31, 2025**\n\n \n\nEstimated federal net operating loss carryforwards\n\n \n$7,000,000\n \n\n \n$8,895,000\n \n\nFederal statutory tax rate\n\n \n\n \n21.0%\n \n\n \n21.0%\n\nDeferred tax asset related to net operating loss carryforwards\n\n \n$1,470,000\n \n\n \n$1,868,000\n \n\nLess: valuation allowance\n\n \n\n \n(1,470,000)\n \n\n \n(1,868,000)\n\n**Net deferred tax asset related to net operating loss carryforwards**\n\n \n$-\n \n\n \n$-\n \n\n \n\nThe Company's federal net operating loss carryforwards were generated after December 31, 2017 and, accordingly, may be carried forward indefinitely, subject to applicable limitations. Utilization of the Company's net operating loss carryforwards may be subject to annual limitations under Section 382 of the Internal Revenue Code in the event of an ownership change. The Company has not completed a formal Section 382 analysis. If an ownership change has occurred, the amount of net operating loss carryforwards available to offset future taxable income could be limited.\n\n \n\nThe Company files income tax returns in the U.S. federal jurisdiction and may file in various state and foreign jurisdictions, as applicable. The Company's income tax filings are subject to examination by taxing authorities for open tax years from inception, April 15, 2021, through the current tax year. As of March 31, 2026 and 2025, the Company did not record any liability for uncertain tax positions, penalties, or interest.\n\n \n\n**Note 6 - Subsequent Events**\n\n \n\nIn accordance with ASC 855, *Subsequent Events*, the Company has evaluated subsequent events through the date the financial statements were issued. Based on this evaluation, the Company has determined that there were no subsequent events requiring adjustment to, or disclosure in, the accompanying consolidated financial statements\n\n \n\n \n\nF-12\n\n*Table of Contents*"}